eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | macular degeneration |
| Symptom | C0019080|hemorrhage |
| Sentences | 19 |
| PubMedID- 20464119 | Intravitreous injection of bevacizumab and c3f8 gas for the treatment of submacular hemorrhage due to age-related macular degeneration: case reports. |
| PubMedID- 23769784 | Objective: to study the visual and anatomic outcomes of serial anti-vascular endothelial growth factor (anti-vegf) therapy for severe macular hemorrhage in eyes with exudative age-related macular degeneration (amd). |
| PubMedID- 23075629 | Aims: to review and discuss the literature on recombinant tissue plasminogen activator (rtpa) for the treatment of a recent-onset submacular hemorrhage in patients with age-related macular degeneration. |
| PubMedID- 22791965 | She had a history of surgical removal of hematoma due to subretinal hemorrhage associated with age-related macular degeneration 5 years ago. |
| PubMedID- 22814924 | Subretinal massive hemorrhage due to exsudative age-related macular degeneration remains a challenging field for submacular surgery. |
| PubMedID- 24531021 | Purpose: to evaluate the outcome of pars plana vitrectomy, subretinal tissue plasminogen activator (t-pa) infusion and intraocular gas tamponade with and without postsurgical antivascular endothelial growth factor (vegf) injection for thick submacular hemorrhage due to exudative age-related macular degeneration (amd). |
| PubMedID- 26212151 | Large submacular hemorrhage, an uncommon manifestation of neovascular age-related macular degeneration, may also occur with idiopathic polypoidal choroidal vasculopathy. |
| PubMedID- 21060269 | Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration. |
| PubMedID- 24534623 | Relationship between intravitreal anti-vegf therapy and subretinal hemorrhage in patients with exudative age-related macular degeneration. |
| PubMedID- 26302314 | Purpose: the aim of this study was to evaluate the surgical outcomes of a modified approach in the management of thick submacular hemorrhage in patients with wet age-related macular degeneration. |
| PubMedID- 20182402 | Results of vitrectomy for breakthrough vitreous hemorrhage associated with age-related macular degeneration and polypoidal choroidal vasculopathy. |
| PubMedID- 22044334 | Treatment for submacular hemorrhage associated with neovascular age-related macular degeneration. |
| PubMedID- 21484631 | Background: submacular hemorrhage is a manifestation of neovascular age-related macular degeneration (amd) that has a very poor natural history leading to severe visual loss. |
| PubMedID- 20668667 | Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tpa injection followed by intravitreal ranibizumab. |
| PubMedID- 23053632 | Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration. |
| PubMedID- 26457037 | Methods: this retrospective, observational study included 49 patients (49 eyes) who initially presented with submacular hemorrhage associated with exudative age-related macular degeneration and who were followed-up for at least 24 months. |
| PubMedID- 22737352 | Intravitreal expansile gas and bevacizumab injection for submacular hemorrhage due to neovascular age-related macular degeneration. |
| PubMedID- 23518899 | Bullous hemorrhagic retinal detachment because of massive subretinal hemorrhage in patients with age-related macular degeneration. |
| PubMedID- 20182401 | Purpose: the purpose of this study was to study the effect of pars plana vitrectomy (ppv) for age-related macular degeneration with vitreous hemorrhage on choroidal neo-vascularization (cnv). |
Page: 1